COSMOS HEALTH INC (COSM)
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-11-04
$0.29-11.51%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-11-04
QuarterlyIQ Insights · COSM
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and has erratic recent earnings surprises. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 2 industry peers
COSM — earnings miss
Dated 2026-10-22
above is incorporated herein by reference. On October 20, 2026, the Company issued its Chief Executive Officer's letter to shareholders providing a 2026 business update. A copy of the afore-mentioned letter is attached hereto as Exhibit 99.2 and incorporated herein by reference. FORWARD-LOOKING STATEMENTS Certain statements contained herein constitute forward-looking statements as such term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities…
Why it matters: Liabilities fell in the first half, but the company also reported $4.15 million in liquid assets. The next balance sheet will show if debt keeps shrinking.
Supportive ifThe Q3 balance sheet shows total liabilities below $40.79 million.
Worry ifThe Q3 balance sheet shows total liabilities at or above $40.79 million.
Why it matters: Q3 revenue was reported as a preliminary estimate. Final results can confirm the record quarter or show a change.
Watch forThe November 13 report confirms Q3 revenue at or above $17.4 million.
Also watch forThe November 13 report puts Q3 revenue below $17.4 million.
Why it matters: Adjusted EBITDA was negative in Q2 and the first half. A positive Q4 result would show progress toward covering costs.
Supportive ifThe Q4 report shows adjusted EBITDA above $0.
Worry ifThe Q4 report shows adjusted EBITDA at or below -$1.13 million, no better than Q2.
Why it matters: Nine-month revenue was about $54.3 million. Q4 revenue above $35.7 million would clear the full-year outlook.
Supportive ifThe November 13 results show Q4 revenue above $35.7 million. Full-year revenue is above $90 million.
Worry ifThe November 13 results show Q4 revenue at or below $35.7 million. Full-year revenue is at or below $90 million.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$529 on $10,000 · ±5.3% | How much price usually moves either way. |
| Bad day | $1,007 loss on $10,000 · 10.1% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $7,641 loss on $10,000 · 76.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Adjusted gross margin was 9.54% in Q2, while first-half GAAP gross margin was 7.84%. The next report can show whether margin gains last.
Supportive ifThe Q4 report shows gross margin above 9.54%. No large reversal of sales discounts lowers reported gross profit.
Worry ifThe Q4 report shows gross margin of 7.84% or less. Or, a sales discount reversal cuts reported gross profit.